NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News $22.86 -0.53 (-2.27%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBRN alerts:Sign Up Key Stats Today's Range$22.86▼$22.8750-Day Range$18.44▼$23.8152-Week Range$17.86▼$28.74Volume213 shsAverage Volume772 shsMarket Capitalization$3.43 millionAssets Under Management$3.43 millionDividend Yield0.44%Net Expense Ratio0.47%Aggregate RatingModerate Buy ETF OverviewThe iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.Read More… iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.57%0.52%0.54%Other Expenses0.00%0.55%0.48%0.56%0.51%Total Expense0.47%0.73%0.72%0.73%0.71%Fee Waiver0.00%-0.69%-0.48%-0.65%-0.54%Net Expense0.47%0.60%0.63%0.58%0.60% Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBRN ETF News HeadlinesBlackRock, Inc. Expands Holdings in iShares Neuroscience and Healthcare ETFJanuary 8, 2025 | gurufocus.comSee More Headlines IBRN ETF - Frequently Asked Questions How have IBRN shares performed this year? iShares Neuroscience and Healthcare ETF's stock was trading at $25.40 at the start of the year. Since then, IBRN stock has decreased by 10.0% and is now trading at $22.86. View the best growth stocks for 2025 here. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings68 Fund Statistics Assets Under Management$3.43 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Options OptionableN/A Short Interest1,800 shs Miscellaneous Outstanding Shares150,000Beta0.71 Creation Unit50,000 Creation Fee$350.00 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Top 10 IBRN HoldingsACADIA Pharmaceuticals (NASDAQ:ACAD)Holding Weight: 5.42%Catalyst Pharmaceuticals (NASDAQ:CPRX)Holding Weight: 5.10%Neurocrine Biosciences (NASDAQ:NBIX)Holding Weight: 4.80%PTC Therapeutics (NASDAQ:PTCT)Holding Weight: 4.29%argenx (NASDAQ:ARGX)Holding Weight: 4.27%Scholar Rock (NASDAQ:SRRK)Holding Weight: 4.12%Alkermes (NASDAQ:ALKS)Holding Weight: 4.00%SK Biopharmaceuticals Co., Ltd.Holding Weight: 3.90%Supernus Pharmaceuticals (NASDAQ:SUPN)Holding Weight: 3.89%Biogen (NASDAQ:BIIB)Holding Weight: 3.82%Full Holdings DetailsIBRN Sector ExposureIBRN Industry Exposure This page (NYSEARCA:IBRN) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
